Hepatitis C virus (HCV) is a major etiological agent of chronic liver disease and hepatocellular carcinoma (HCC). We demonstrate herewith that HCV core proteins encoded by sequences isolated from HCC tumor tissues, but not those derived from their non-tumor counterparts in the same liver, co-localise in vitro and in vivo and co-immunoprecipitate with PKR in hepatocytic Huh7 cells. We show that this association in fact augments the autophosphorylation of PKR and the phosphorylation of the translation initiation factor eIF2a, which are two markers of PKR activity. The present study therefore identi®es a novel model of viruscell interactions whereby a viral protein, the HCV core, activates PKR activity. Oncogene (2001) 20, 5836 ± 5845.
Introduction
Hepatitis C virus (HCV) infection is highly prevalent world-wide and is characterized by a very high rate (70 ± 80%) of progression to a chronic carrier state, as well as a risk of developing liver cirrhosis and hepatocellular carcinoma (HCC) (Lai and Ware, 2000; Shimotohno, 1995 Shimotohno, , 2000 . The molecular basis for the frequent resistance of HCV to interferon a (IFNa) therapy is poorly understood (see reviews in Brechot, 1998; McHutchison and Poynard, 1999; Sarrazin and Zeuzem, 1999) . HCV is a positivestranded RNA virus, belonging to the Flaviviridae; its polyprotein is cleaved in structural (core and envelope E1 and E2) and non-structural (NS2-NS5B) proteins which act at dierent stages of protein cleavage, viral genome replication and protein assembly (Major and Feinstone, 1997; Santolini et al., 1994) .
Hepatocellular carcinoma is a long term complication of HCV infection, the tumor developing about 10 ± 20 years after acute infection as a complication of liver cirrhosis (see review in Shimotohno, 1995 Shimotohno, , 2000 . Chronic liver in¯ammation and ®brosis, the major histological features of chronic active hepatitis and cirrhosis, are major mechanisms of HCV-related liver carcinogenesis; there is also some evidence for a direct modulation of liver cell viability and proliferation by HCV protein expression, such as the viral core, E2 NS3 and NS5A proteins (reviews in Lai and Ware, 2000; McLauchlan, 2000; Tsuchihara et al., 1999 , Neddermann et al., 1997 . Several studies have in particular established that HCV core, a 191 amino acid basic protein with RNA binding activity, regulates important cellular signals, such as those which control NF-kB-, AP 1-and SRE-activities, MAP kinases, raf, P53 and P21 (Lai and Ware, 2000; Marusawa et al., 1999; Otsuka et al., 2000; Tsuchihara et al., 1999) . HCV core has been described as being associated with lymphotoxin-b receptor, TNF-receptor 1, apolipoprotein AII, hnRNP and a bZIP transcription factor (Barba et al., 1997; Chen et al., 1997; Hsieh et al., 1998; Sabile et al., 1999) . Evidence exists that HCV core may have an eect upon cell transformation (Jin et al., 2000) and apoptosis (Marusawa et al., 1999; Ray et al., 1996 Ray et al., , 1998 Ruggieri et al., 1997) ; however, the biological consequences of core ectopic expression depend on the levels of expression achieved, the cell type utilized and the cellular environment (Honda et al., 2000; Zhu et al., 1998) .
In this context, we reasoned that analysing in vivo the virus-cell interaction at the stage of HCC development should provide valuable information on the mechanisms favoring long term viral persistence as well as, possibly, the direct impact of HCV core on cell viability and proliferation. We, therefore, based our study on a comparative analysis of the properties of full length natural mutants of core-encoding sequences, isolated from HCC tumor and non-tumor tissues. There is ample evidence that PKR plays a major role in controlling both the IFN antiviral activity and cell viability (Gil et al., 1999; Kaufman, 1999; Williams, 1999) . The inactivation of PKR has been reported in several cases of viral infections (Williams, 1999; Yeung et al., 1999) . Given the reported inhibition of PKR activity by HCV envelope E2 (Taylor et al., 1999) and NS5A (Gale et al., 1998; proteins, and the eects of HCV core on cellular signal transduction, we investigated the potential impact of core expression on this major regulatory pathway.
Results
Full-length core sequences were ampli®ed from tumor (T) and non-tumor (NT) (cirrhotic) tissues from two genotype 1b-infected patients (patients A and B) with HCC (referred to as AT (1 to 4), ANT (1 to 5), BT (1 to 3) and BNT (1 to 3); (Figure 1) ). Sequence analysis of HCV quasispecies distribution (10 clones for each sample), combined with direct sequencing, allowed us to choose those clones which corresponded to the most prevalent HCV core sequences: AT1; ANT1 and 2; BT1 and 2; BNT1. Comparison between tumor and non tumor-derived core sequences showed a small number of amino acid changes, without any preferentail location within the putative core domains. We failed to achieve stable core expression in the welldierentiated, human hepatoma cell line Huh7; thus in order to investigate the biological eects of core protein in the context of hepatocytes, and to overcome genetic events secondary to clonal selection, we achieved an eciency and reproducible method for transient transfection of this Huh7 hepatocytic cell line (about 40 ± 50% transfected cells). We were able to obtain reproducible and comparable core expression for the six sequences tested. We also veri®ed that HCV core expression was not modi®ed by interferon a (Figures 2a and 3a) . We ®rst investigated whether HCV core might directly bind PKR. We analysed the sub-cellular localisation of core and PKR. Core showed a cytoplasmic localisation consistent with that previously reported in dierent cell lines (Barba et al., 1997; Sabile et al., 1999; Yasui et al., 1998) . Confocal analysis revealed co-localization, in the presence or absence of IFNa treatment (data not shown), of cores expressed from the tumor-derived sequences (AT1, BT1 and BT2), and not the non tumor-derived sequences-(ANT1, ANT2 and BNT1), and PKR (Figure 2a) . The interaction between core and PKR was con®rmed by co-immunoprecipitation experiments. AT1, BT1 and BT2 but not ANT1-2, BNT1-encoded cores were revealed after immunopreciptation with an anti-PKR antibody (Figure 2b ). Taken together, the results of these co-localization and co-immunoprecipitation assays were entirely consistent and demonstrated a speci®c association between tumor derived-HCV cores and PKR. None of the six core sequences tested had any detectable eect on the level of PKR expression, with or without IFNa-treatment (Figure 3a) .
We then determined whether HCV core might aect the activity of PKR. Endogenous PKR was immunoprecipitated and analysed for autophosphorylation. As shown in Figure 3b ,d, PKR precipitated from Huh7 cells transfected with AT1, BT1 and BT2 sequences, exhibited a 2-3-fold increase in autophosphorylation on PolyI-PolyC stimulation, when compared with those transfected with empty vector (T-), ANT1 and 2 and BNT1-encoding sequences (Figure 3b,d ). This result suggested that core might activate PKR in vivo, and was con®rmed by examination of the expression of the phosphorylated and non-phosphorylated eIF2a: a major target for PKR kinase activity (Lu et al., 1999) . Transient expression of AT1, BT1 and BT2 after PolyI-PolyC stimulation also gave rise to an average 2 ± 3-fold increase in the ratio of phosphorylated versus non-phosphorylated forms of eIF2a, when compared with that observed upon ANT1, ANT2 and BNT1 expression ( Figure 3c,d) ; endogenous PKR activity was assessed in cells transiently transfected with the core-encoding constructs and thus the magnitude of its activation was probably underestimated. Thus, two complementary assays were reproduced during three independent experiments and demonstrated a signi®cant increase of PKR activity in tumor-derived HCV core-expressing hepatocyte cells. Representative results are shown here for each experiment.
To further support in vivo relevance of this observation, we investigated liver tissues from patients A and B and from eight other patients with HCVrelated HCC. We analysed tumor and non-tumor liver sections for PKR and core expression. We were able to demonstrate HCV core/PKR co-localization in all 10 HCC tissues tested, but not in the non-tumor counterparts from the same patients (representative results in Figure 4a ); the speci®city of this result was veri®ed by the negative staining obtained when primary anti-HCV antibody was omitted, and the very limited background observed when applying anti-HCV antibodies to section from normal liver (Figure 4b ) or livers with lesions unrelated to HCV infection (data not shown). Some studies have suggested that NS5A may bind PKR and inhibits its activity (Gale et al., 1998) . We recently reported, however, that at least in Huh7 cells, we did not show such an interaction (Podevin et al., 2001) . These very important results turned to advantage, providing additional evidence for the speci®city of our present observations on HCV core. Thus, under the same experimental conditions, we showed that NS5A encoding sequences derived from tumor and non-tumor tissues from the same patients A and B did not colocalise with PKR, in vitro ( There is evidence that PKR may play a role in apoptosis (Kaufman, 1999; and HCV core sequences might also modulate cell viability (McLauchlan, 2000; Tsuchihara et al., 1999) . We therefore tested whether tumor and non tumor-derived HCV core sequence expression might have an impact on cell viability ( Figure 5 ). Apoptosis was assessed from nuclear morphology following DAPI and Actinomycin D staining ( Figure 5a , 1 ± 4) and annexin V externalization (Figure 5b ,c). The rate of apoptosis Figure 1 HCV core sequences from tumor and non tumor HCC tissues (amino acid alignment). Fifteen full length core sequences were derived from two genotype 1b-infected patients (A and B). ANT1 to 5 and BNT1 to 3 refer to sequences from the non-tumor tissue of patients A and B, respectively; AT1 to 4; BT1 to 3 refer to sequences from the tumor tissues of patients A and B. Dashes indicate amino-acid residues identical to those of a reference 1b sequence (HCV J). The number (n) represents the prevalence of the HCV quasispecies distribution Activation of PKR by tumor-derived HCV core protein N Delhem et al upon stimulation by TNFa (+CHX) did not dier in cells expressing tumor and non tumor-derived core (about 10 ± 15% of annexin V positive cells) but was increased, compared with that observed in cells transfected with the empty vector (4 ± 5%; Figure 5b ). We then attempted to correlate this observation with the changes to PKR activity discussed above. Stimulation by IFNa or PolyI-PolyC alone in these cells only weakly induced apoptosis (data not shown). We therefore investigated whether co-stimulation by IFNa (or PolyI-PolyC) and TNFa might further enhance apoptosis and how HCV core expression could in¯uence this eect. Huh7 cells expressing the tumorand non tumor-derived cores, but not the empty vector, did show increased apoptosis; the mean ratio between TNFa (+CHX) alone and IFNa-TNFa combination (R in Figure 5b ,c) ranging between 1.51 to 4.45; however, the magnitude of apoptosis ampli®-cation, observed upon treatment with a IFNa/TNFa combination, was signi®cantly higher in those cells expressing tumor-derived AT1 and BT1, compared with the non tumor-derived core sequences ANT1 and BNT1 (P50.018, Figure 5c ). Comparable results were obtained using PolyI-PolyC instead of IFNa for Huh7 stimulation (data not shown). Overall, these ®ndings con®rmed the impact of HCV core on cell viability; further, correlation of the results obtained concerning tumor-derived cores eects on PKR activity and apoptosis, as well as the eect of PolyI-PolyC, suggested the implication of PKR.
Discussion
Overall, our study demonstrates the speci®c association of HCV core protein expressed from HCC tumor tissues with PKR, leading to an increased activity of the kinase. It therefore provides the ®rst evidence of the existence of a viral activator of PKR activity. The association of HCV core and PKR was assessed by both co-localization and co-immunoprecipitation and its relevance was con®rmed in vivo in the context of a productive viral infection. These results exactly correlated with those observed for PKR autophosphoryla- tion and eIF2a phosphorylation (Gil et al., 1999) . Strikingly, only HCV cores expressed from the tumorderived sequences associated with PKR and increased its activity, although non tumor-derived cores were expressed at the same levels under exactly the same experimental conditions. The six HCV core sequences investigated diered only by a few amino acids changes, and it was not possible to identify a common pro®le of mutations associated with PKR-binding activity; this observation may suggest conformational changes and the involvement of distinct HCV core moieties. These ®ndings raise several important issues regarding the biological role of PKR in liver cells and the pathogenesis of HCV infection. There is ample evidence for the important role of PKR in the antiviral eect of interferon (Lee et al., 1996; Sen and Ransoho, 1993; Williams, 1999) . PKR is also activated by several nonviral stimuli, such as stress-dependent signals and cytokine deprivation. Several studies have dissected the mechanisms employed by many viruses to inhibit this antiviral eect and thus promote viral persistence (Clemens and Elia, 1997; . As for HCV, it has been shown that NS5A (Gale et al., 1998; expression inhibits the global antiviral eect of interferon, as assayed by viral rescue experiments (Song et al., 1999 , Polyak et al., 1999 . HCV polyprotein expression impairs interferon-dependent signal transduction and in particular STAT DNA binding ecacy (Gale et al., 1998; Heim et al., 1999; Polyak et al., 1999) . Furthermore, it has been proposed that two HCV proteins: E2 and NS5A, may bind PKR, inhibit its antiviral and anti-apoptotic activities and thus favor HCV chronicity and liver cell clone expansion (Gale et al., 1998; Taylor et al., 1999) ; the results concerning NS5A may dier depending on the cell line examined and we were unable to show such an association in HuH7 cells (Podevin et al., 2001) . Nevertheless, the present results allow us to propose an alternative, and in fact contrasting mechanism for HCV core protein. HCV replicates and circulates as a quasi-species (Lee et al., 1997). Our observations imply that the liver cell proliferation observed during liver carcinogenesis is associated with the selection of viral genomes whose core products activate PKR. This apparently paradoxical ®nding should be discussed in the light of two important observations. Firstly, antiviral PKR activity has been demonstrated on viruses with cap-dependent translation control, while HCV polyprotein translation is capindependent (Major and Feinstone, 1997); it is possible that modifying the balance between cap-dependent and independent translation controls may be important to the overall antiviral eect of PKR (Lee et al., 1996) . Consistent with previous reports (Shimotohno, 2000) , we observed a marked reduction in HCV multiplication in HCC tumor cells (data not shown). Strong arguments exist in favor of the importance of the immune response to HCV proteins in liver cell destruction during acute or chronic HCV infection, our ®ndings therefore suggest that the activation of PKR may reduce HCV protein expression and the elimination of infected cells, thus favoring viral persistence. A sustained reduction in HCV replication during the later stages of liver cancer development would then probably depend on other mechanisms, such as the lack in dedierentiated cancer cells of the tissue-speci®c cellular factors necessary for HCV polyprotein expression and maturation. Interestingly, a recent report described the increased transcription of the gene encoding another interferon-induced cellular protein, 2' ± 5' oligoadenylate synthetase, on HCV core expression, further supporting such hypotheses (Naganuma et al., 2000) .
Our ®ndings should also be seen in the light of the reported pro-apoptotic activity of PKR. The expression of both tumor-and non tumor-derived cores sensitized Huh7 cells to TNFa stimulation, further supporting the role of this viral protein in modulating liver cell viability during chronic liver in¯ammation. Importantly, we also saw increased apoptosis of Huh7 cells further stimulated by IFNa and expressing tumorderived cores, which correlated with increased PKR activity. This, as well as the similar results obtained with PolyI-PolyC, is consistent with the implication of PKR in Huh7 cell apoptosis. These properties of HCV cores isolated from clonally expanding tumor cells may appear paradoxical. Increased PKR expression has been documented in cancer cells, but its activity was in fact decreased; it should however be noted that increased PKR activity was recently described in breast cancer-derived cell lines (Kim et al., 2000) . In this setting, it is plausible that, in the context of liver in¯ammation and the secretion of cytokines such as IFN and TNFa, augmented PKR activity might increase cell apoptosis, favoring the selection of a cell subset which has acquired resistance to HCV coredependent apoptosis and which dierentiation status maintain downregulated HCV multiplication. Consistent with this hypothesis, PKR has been shown to accumulate in well-dierentiated HCC tumor cells (both HBV-and HCV-related) (Shimada et al., 1998) . It should also be remembered that PKR may exert other biological eects and, in particular, triggers the cell cycle progression (Williams, 1999) .
We cannot rule out that the biological eects of these core proteins might dier in the context of full length HCV polyprotein expression. Given the low HCV multiplication, it is at present not feasible to synthetize full-length HCV cDNA from these tumor samples; nevertheless, we clearly establish the biological signi®cance of core-encoding sequence mutations, selected in vivo upon long term persistence of HCV and cellular clonal expansion. Taken together, these data encourage us to propose a novel paradigm for the interaction between a viral protein and PKR and the impact of this interaction on viral persistence and carcinogenesis. Cellular activators of PKR have been described which regulate its physiological activities in the absence of doublestranded RNA (Patel and Sen, 1998; Williams, 1999) . To date, several viruses have been shown to employ dierent strategies to inhibit PKR signalling. To our knowledge, this study is the ®rst to propose that certain viral proteins implicated in oncogenesis may in fact act as activators of PKR activity.
Materials and methods

Plasmid constructs
Six full length core sequences were ampli®ed from tumoral (T) and non-tumoral cirrhotic (NT) liver tissues of two patients infected with HCV 1b. HCV-RNA was extracted from frozen tissue and 5 ml of puri®ed RNA was used to generate cDNA in a 20 ml reaction mixture at 378C for 1 h with 20 U of Moloney murine leukemia virus RT (Gibco-BRL, France). HCV core sequences were ampli®ed using a single round PCR assay: forward primer (and positions relative to the HCV-1 genome 5' terminus) were as follows: outer forward (nt750 to 740) and reverse primer (nt+628 to +607). PCR products were directly sequenced and inserted into plasmid pDP18 (Shimotohno, 2000) under the control of a RSV promotor.
Transient core expression in Huh7 cells
The human hepatoma Huh7 cell line was grown in Dulbecco's modi®ed eagle medium (DMEM, Life Technologies) supplemented with 10% fetal calf serum (FCS: Life Technologie), 2 mM L-glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin. Using 10 ml per transfection of the Exgen 500 transfection reagent (Poly-Ethyl-Imine, Euromedex), cells were transiently transfected in OPTIMEM I medium (Life Technologies) with 5 mg of the various core expressing plasmids or of the empty vector. In order to normalize the transfection eciency, the Huh7 cells were also cotransfected with a plasmid expressing the b-Galactosidase. After 5 ± 6 h, the transfected cells were then diluted in 10 ml of DMEM supplemented with 10% FCS (Life Technologies), and reseeded for 48 h either untreated or treated by human recombinant IFNa-2a (500 U/ml) (Roche, France) or PolyIpolyC (100 mg/ml) (Pharmacia, Biotech) during the last 18 h of cell culture.
SDS ± PAGE and Western-blotting
Huh7 cells were lysed in situ, in 20 mM Tris-Hcl, pH 7.5 buer containing 5 mM EDTA and 100 mM KCl. The homogenate was centrifugated at 6000 r.p.m. for 10 min. Proteins (50 mg) in the supernatant were loaded onto an SDS-12% polyacrylamide gel, transferred onto a 0.22 nm nitrocellulose membrane and blotted using monoclonal anticore (Euromedex clone 126) (1/500); polyclonal anti-PKR (1/ 1250) (Santa-Cruz Biotechnology), polyclonal anti-tubulin (Amersham) (1/2000), polyclonal anti-eIF2a (1/1000) and anti-phosporylated eIF2a (Research Genetics Inc) (1/1000) antibodies. Blots were incubated with the peroxydase-coupled secondary antibody (1/2000) (Amersham; Pharmacia) and proteins were visualized using a chimioluminescence detection kit (ECL, Amersham; Pharmacia).
PKR Autophosphorylation
Transfected cells were lysed in 20 mM Tris pH 7.6, 50 mM KCl, 400 mM NaCl, 1 mM EDTA, 5 mM b-mercaptoethanol, 1% triton, 0.2 mM PMSF, 100 mg/ml aprotinin and 20% glycerol. For immunoprecipitation, 100 mg total proteins were incubated overnight at 48C with 1 ml of monoclonal anti-PKR antibody (1/100) (Ribogene), and 40 ml of protein Gsepharose (Amersham, Pharmacia). The beads were washed three times and resuspended in 40 ml of 20 mM Tris pH 7.5, 80 mM KCl, 2 mM MgCl 2 , 2 mM MnCl 2 , 5 mM b-mercaptoethanol and 20% glycerol, supplemented with 32 P[g-ATP], 2 mM ATP and 100 mg/ml of polyI-polyC. After 30 min incubation at 308C, the beads were solubilized in Laemmli buer and subjected to electrophoresis on a 8%-polyacrylamide gel and transferred into a nitrocellulose membrane. Labeled PKR was revealed and analysed using a phosphorimager.
Immunofluorescence analyses
Immuno¯uorescence analyses were performed 48 h posttransfection. The core transfected Huh7 cells, treated or not with IFNa, were ®xed in paraformaldehyde 4%-PBS for 10 min at room temperature and permeabilized for 10 min in ice-cold methanol. The transfected cells were washed three times with PBS and then incubated for 1 h with a primary monoclonal mouse anti-core (Euromedex, clone 126) (1/200) or a polyclonal rabbit anti-PKR (Santa-Cruz, Biotechnology) (1/200). Then the secondary antibodies labeled with¯uor-escein (1/200) (anti-mouse/FITC) and texas red (anti-rabbit/ TR) (1/200) were added for 1 h at room tempeÂ rature. Coverslips were mounted in 90% Glycerol-PBS and analysed on an epi¯uorescence microscope (Olympus) or using confocal laser scanning microscopy (Zeiss, F510).
Co-immunoprecipitation analysis
The Huh7 transfected cells were lysed in 20 mM Tris pH 7.6, 50 mM KCl, 400 mM NaCl, 1 mM EDTA, 5 mM bmercaptoethanol, 1% triton, 0.2 mM PMSF, 100 mg/ml aprotinin and 20% glycerol. Total proteins (100 mg) were incubated overnight at 48C with 1 ml of polyclonal anti-PKR antibody (1/100) (Santa Cruz, Biotechnology) and 40 ml of protein G-sepharose (Amersham; Pharmacia). The beads were washed three times and resuspended in 40 ml of 20 mM Tris pH 7.5, 80 mM KCl, 2 mM MgCl 2 , 2 mM MnCl 2 , 5 mM b-mercaptoethanol and 20% glycerol. They were then solubilized in Laemmli buer and centrifuged at 10 000 g. As described above The supernatant was subjected to electrophoresis on a 12% polyacrylamide gel, transferred onto nitrocellulose membrane and blotted, using ®rst the polyclonal anti-PKR (1/1250) and then the monoclonal anti-core (1/500) antibodies.
In situ immunofluorescence analysis
Tumor and non-tumor liver biopsies from 10 HCV positive patients with HCC were placed in OCT compound (MILES-Elkhart) and snap frozen in liquid nitrogen for subsequent immuno¯uorescence analysis. Brie¯y, the 5 mm frozen sections were ®xed in cold acetone for 10 min at room temperature (RT). After permeabilization with 0.5% triton X100; 0.1% deoxycholate in phosphate buered saline (PBS) for 30 min at RT, slides were incubated with primary antibodies (monoclonal mouse anti-core: Euromedex, clone 126; polyclonal rabbit anti-PKR: Santa-cruz; monoclonal mouse anti-NS5A: Euromedex) diluted 1/40, 1/100 and 1/80 respectively in PBS 2% FCS, 0.1% triton X100, for 48 h at 48C. After washing and blocking with PBS-2% FCS for 30 min at 378C, the secondary antibodies (anti mouse/FITC and anti-rabbit/TR) diluted 1/200, were added for 1 h. The slides were washed ®ve times with PBS and were mounted in immunomount (Shandon) and analysed by confocal laser scanning microscopy.
Determination of apoptosis
TNFa or IFNa alone did not induce signi®cant apoptosis of Huh7 cells. Thus, transiently transfected Huh7 cells were sensitized either by TNFa (Sigma: 20 ng/ml) and CHX (Tebu: 40 nM/ml) for the last 8 h of cell culture or by combining TNFa and CHX with IFNa (500 U, 18 h). After 48 h of transfection, the transfected cells were ®xed with formaldehyde 1%/glutaraldehyde 0.2% in PBS for 5 min at room temperature and stained with 4,6 diamidino-2 phenylindole (DAPI) (1/100) (Tebu) in PBS for 10 min, washed in PBS and mounted with glycerol/PBS 90%. Apoptotic nuclei were identi®ed on the basis of condensed chromatin and nuclear fragmentation. Apoptosis was also determined by Annexin V membrane staining according to manufacturer's instruction (Annexin V-FITC detection KIT, Pharmingen International). After TNFa treatement, the transfected Huh7 cells were washed twice with cold PBS and resuspended in 16binding buer (10 mM Hepes/NaOH, pH 7.4, 140 mM NaCl, 2.5 mM CaCl 2 ) at a concentration of 1.10 6 cells/ml. One hundred ml of the solution (1610 5 cells) were transfered to 5 ml culture tube. Then, 5 ml of Annexin-V-FITC and 10 ml of PI (propidium iodide) were added and gently vortexed. Cells were incubated for 15 min at room temperature in the dark and 400 ml of 16binding buer were added to each tube before analysing by¯ow cytometrie within 1 h.
Abbreviations CHX: Cycloheximide, HCV: Hepatitis C Virus, IFNa: Interferon alpha, PKR: double-stranded RNA-dependent protein kinase, TNFa: Tumor Necrosis Factor
